Published in
Wiley Open Access, Cancer Science, 3(114), p. 995-1006, 2022
DOI: 10.1111/cas.15642
Links
Tools
Clinical outcomes of second‐generation tyrosine kinase inhibitors versus imatinib in older patients with CML
Journal article published in 2022 by
Takaaki Ono 
,
Naoto Takahashi ,
Masahiro Kizaki,
Tatsuya Kawaguchi,
Ritsuro Suzuki ,
Kazuhito Yamamoto ,
Kazunori Ohnishi,
Tomoki Naoe,
Itaru Matsumura
,
Naoto Takahashi ,
Masahiro Kizaki,
Tatsuya Kawaguchi,
Ritsuro Suzuki ,
Kazuhito Yamamoto ,
Kazunori Ohnishi,
Tomoki Naoe,
Itaru Matsumura
This paper is made freely available by the publisher.
Full text: Download
Data provided by 